img

Global Nano Antibodies Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nano Antibodies Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Nanoantibodies or "nAb" are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages

Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability
Nano Antibodies report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nano Antibodies market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Disease detection in vitro and Non-invasive diagnosis in vivo are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nano Antibodies industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Nano Antibodies key companies include Ablynx, PREGENE, Alphamab and PersonGen, etc. Ablynx, PREGENE, Alphamab are top 3 players and held % share in total in 2022.
Nano Antibodies can be divided into Monovalent Nanobody, Multivalent and multispecific Nanobodies and Fusion Nanobody,, etc. Monovalent Nanobody is the mainstream product in the market, accounting for % share globally in 2022.
Nano Antibodies is widely used in various fields, such as Disease detection in vitro, Non-invasive diagnosis in vivo, Tumor targeted therapy and Nervous system disease, etc. Disease detection in vitro provides greatest supports to the Nano Antibodies industry development. In 2022, global % share of Nano Antibodies went into Disease detection in vitro filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nano Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Ablynx
PREGENE
Alphamab
PersonGen
Segment by Type
Monovalent Nanobody
Multivalent and multispecific Nanobodies
Fusion Nanobody

Segment by Application


Disease detection in vitro
Non-invasive diagnosis in vivo
Tumor targeted therapy
Nervous system disease
Circulatory disease
Infectious disease
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nano Antibodies market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nano Antibodies introduction, etc. Nano Antibodies Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Nano Antibodies market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Nano Antibodies
1.1 Nano Antibodies Market Overview
1.1.1 Nano Antibodies Product Scope
1.1.2 Nano Antibodies Market Status and Outlook
1.2 Global Nano Antibodies Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Nano Antibodies Market Size by Region (2024-2034)
1.4 Global Nano Antibodies Historic Market Size by Region (2024-2024)
1.5 Global Nano Antibodies Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Nano Antibodies Market Size (2024-2034)
1.6.1 North America Nano Antibodies Market Size (2024-2034)
1.6.2 Europe Nano Antibodies Market Size (2024-2034)
1.6.3 Asia-Pacific Nano Antibodies Market Size (2024-2034)
1.6.4 Latin America Nano Antibodies Market Size (2024-2034)
1.6.5 Middle East & Africa Nano Antibodies Market Size (2024-2034)
2 Nano Antibodies Market by Type
2.1 Introduction
2.1.1 Monovalent Nanobody
2.1.2 Multivalent and multispecific Nanobodies
2.1.3 Fusion Nanobody
2.2 Global Nano Antibodies Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Nano Antibodies Historic Market Size by Type (2024-2024)
2.2.2 Global Nano Antibodies Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Nano Antibodies Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Nano Antibodies Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Nano Antibodies Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Nano Antibodies Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Nano Antibodies Revenue Breakdown by Type (2024-2034)
3 Nano Antibodies Market Overview by Application
3.1 Introduction
3.1.1 Disease detection in vitro
3.1.2 Non-invasive diagnosis in vivo
3.1.3 Tumor targeted therapy
3.1.4 Nervous system disease
3.1.5 Circulatory disease
3.1.6 Infectious disease
3.1.7 Other
3.2 Global Nano Antibodies Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Nano Antibodies Historic Market Size by Application (2024-2024)
3.2.2 Global Nano Antibodies Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Nano Antibodies Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Nano Antibodies Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Nano Antibodies Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Nano Antibodies Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Nano Antibodies Revenue Breakdown by Application (2024-2034)
4 Nano Antibodies Competition Analysis by Players
4.1 Global Nano Antibodies Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nano Antibodies as of 2022)
4.3 Date of Key Players Enter into Nano Antibodies Market
4.4 Global Top Players Nano Antibodies Headquarters and Area Served
4.5 Key Players Nano Antibodies Product Solution and Service
4.6 Competitive Status
4.6.1 Nano Antibodies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Ablynx
5.1.1 Ablynx Profile
5.1.2 Ablynx Main Business
5.1.3 Ablynx Nano Antibodies Products, Services and Solutions
5.1.4 Ablynx Nano Antibodies Revenue (US$ Million) & (2024-2024)
5.1.5 Ablynx Recent Developments
5.2 PREGENE
5.2.1 PREGENE Profile
5.2.2 PREGENE Main Business
5.2.3 PREGENE Nano Antibodies Products, Services and Solutions
5.2.4 PREGENE Nano Antibodies Revenue (US$ Million) & (2024-2024)
5.2.5 PREGENE Recent Developments
5.3 Alphamab
5.3.1 Alphamab Profile
5.3.2 Alphamab Main Business
5.3.3 Alphamab Nano Antibodies Products, Services and Solutions
5.3.4 Alphamab Nano Antibodies Revenue (US$ Million) & (2024-2024)
5.3.5 PersonGen Recent Developments
5.4 PersonGen
5.4.1 PersonGen Profile
5.4.2 PersonGen Main Business
5.4.3 PersonGen Nano Antibodies Products, Services and Solutions
5.4.4 PersonGen Nano Antibodies Revenue (US$ Million) & (2024-2024)
5.4.5 PersonGen Recent Developments
6 North America
6.1 North America Nano Antibodies Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nano Antibodies Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nano Antibodies Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nano Antibodies Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nano Antibodies Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nano Antibodies Market Dynamics
11.1 Nano Antibodies Industry Trends
11.2 Nano Antibodies Market Drivers
11.3 Nano Antibodies Market Challenges
11.4 Nano Antibodies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Nano Antibodies Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Nano Antibodies Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Nano Antibodies Market Size Share by Region (2024-2024)
Table 4. Global Nano Antibodies Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Nano Antibodies Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Nano Antibodies Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Nano Antibodies Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Nano Antibodies Revenue Market Share by Type (2024-2024)
Table 9. Global Nano Antibodies Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Nano Antibodies Revenue Market Share by Type (2024-2034)
Table 11. North America Nano Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Nano Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Nano Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Nano Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Nano Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Nano Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Nano Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Nano Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Nano Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Nano Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Nano Antibodies Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Nano Antibodies Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Nano Antibodies Revenue Market Share by Application (2024-2024)
Table 24. Global Nano Antibodies Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Nano Antibodies Revenue Market Share by Application (2024-2034)
Table 26. North America Nano Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Nano Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Nano Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Nano Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Nano Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Nano Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Nano Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Nano Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Nano Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Nano Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Nano Antibodies Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Nano Antibodies Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nano Antibodies as of 2022)
Table 39. Date of Key Players Enter into Nano Antibodies Market
Table 40. Global Nano Antibodies Key Players Headquarters and Area Served
Table 41. Nano Antibodies Product Solution and Service
Table 42. Global Nano Antibodies Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Ablynx Basic Information List
Table 45. Ablynx Description and Business Overview
Table 46. Ablynx Nano Antibodies Products, Services and Solutions
Table 47. Revenue (US$ Million) in Nano Antibodies Business of Ablynx (2024-2024)
Table 48. Ablynx Recent Developments
Table 49. PREGENE Basic Information List
Table 50. PREGENE Description and Business Overview
Table 51. PREGENE Nano Antibodies Products, Services and Solutions
Table 52. Revenue (US$ Million) in Nano Antibodies Business of PREGENE (2024-2024)
Table 53. PREGENE Recent Developments
Table 54. Alphamab Basic Information List
Table 55. Alphamab Description and Business Overview
Table 56. Alphamab Nano Antibodies Products, Services and Solutions
Table 57. Revenue (US$ Million) in Nano Antibodies Business of Alphamab (2024-2024)
Table 58. Alphamab Recent Developments
Table 59. PersonGen Basic Information List
Table 60. PersonGen Description and Business Overview
Table 61. PersonGen Nano Antibodies Products, Services and Solutions
Table 62. Revenue (US$ Million) in Nano Antibodies Business of PersonGen (2024-2024)
Table 63. PersonGen Recent Developments
Table 64. North America Nano Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 65. North America Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 66. Europe Nano Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 67. Europe Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 68. Asia-Pacific Nano Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 69. Asia-Pacific Nano Antibodies Market Size by Region (2024-2024) & (US$ Million)
Table 70. Asia-Pacific Nano Antibodies Market Size by Region (2024-2034) & (US$ Million)
Table 71. Asia-Pacific Nano Antibodies Market Share by Region (2024-2024)
Table 72. Asia-Pacific Nano Antibodies Market Share by Region (2024-2034)
Table 73. Latin America Nano Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 74. Latin America Nano Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 75. Latin America Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 76. Middle East & Africa Nano Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 77. Middle East & Africa Nano Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 78. Middle East & Africa Nano Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 79. Nano Antibodies Market Trends
Table 80. Nano Antibodies Market Drivers
Table 81. Nano Antibodies Market Challenges
Table 82. Nano Antibodies Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nano Antibodies Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Nano Antibodies Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Nano Antibodies Market Share by Regions: 2022 VS 2034
Figure 4. Global Nano Antibodies Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Nano Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Nano Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Nano Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Nano Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Nano Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Monovalent Nanobody
Figure 11. Global Monovalent Nanobody Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Multivalent and multispecific Nanobodies
Figure 13. Global Multivalent and multispecific Nanobodies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Fusion Nanobody
Figure 15. Global Fusion Nanobody Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global Nano Antibodies Market Size Share by Type: 2022 & 2034
Figure 17. North America Nano Antibodies Revenue Market Share by Type (2024-2034)
Figure 18. Europe Nano Antibodies Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific Nano Antibodies Revenue Market Share by Type (2024-2034)
Figure 20. Latin America Nano Antibodies Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa Nano Antibodies Revenue Market Share by Type (2024-2034)
Figure 22. Disease detection in vitro Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Non-invasive diagnosis in vivo Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Tumor targeted therapy Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Nervous system disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Circulatory disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Infectious disease Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 29. Global Nano Antibodies Market Size Share by Application: 2022 & 2034
Figure 30. North America Nano Antibodies Revenue Market Share by Application (2024-2034)
Figure 31. Europe Nano Antibodies Revenue Market Share by Application (2024-2034)
Figure 32. Asia-Pacific Nano Antibodies Revenue Market Share by Application (2024-2034)
Figure 33. Latin America Nano Antibodies Revenue Market Share by Application (2024-2034)
Figure 34. Middle East and Africa Nano Antibodies Revenue Market Share by Application (2024-2034)
Figure 35. Nano Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 36. Global Top 5 and Top 10 Players Nano Antibodies Market Share in 2022
Figure 37. North America Nano Antibodies Market Share by Country (2024-2034)
Figure 38. U.S. Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 39. Canada Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 40. Germany Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 41. France Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 42. U.K. Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 43. Italy Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 44. Russia Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 45. Nordic Countries Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 46. Asia-Pacific Nano Antibodies Market Share by Region (2024-2034)
Figure 47. China Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 48. Japan Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 49. South Korea Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 50. Southeast Asia Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 51. India Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 52. Australia Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 53. Latin America Nano Antibodies Market Share by Country (2024-2034)
Figure 54. Mexico Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 55. Brazil Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 56. Middle East & Africa Nano Antibodies Market Share by Country (2024-2034)
Figure 57. Turkey Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 58. Saudi Arabia Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 59. UAE Nano Antibodies Market Size (2024-2034) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries